Secondary Haemochromatosis, also known as secondary iron overload, is a medical condition characterized by excessive accumulation of iron in the body. It is considered a secondary form of haemochromatosis because it is caused by an underlying condition or factor, rather than being inherited like primary haemochromatosis.
Iron overload occurs when the body absorbs and stores more iron than it needs. In secondary haemochromatosis, this excess iron is typically a result of another medical condition or external factor. Some common causes include:
Recognizing the symptoms of secondary haemochromatosis can be challenging as they often overlap with the symptoms of the underlying condition. However, common signs may include fatigue, joint pain, abdominal pain, weakness, and skin discoloration.
Diagnosis of secondary haemochromatosis involves a combination of medical history evaluation, physical examination, blood tests, and imaging studies. These help determine the underlying cause and assess the extent of iron overload.
Treatment for secondary haemochromatosis primarily focuses on managing the underlying condition and reducing iron levels in the body. This may involve therapeutic phlebotomy (removal of blood), iron chelation therapy (medications that bind and remove excess iron), or dietary modifications to limit iron intake.
It is important for individuals with secondary haemochromatosis to work closely with their healthcare providers to develop a personalized treatment plan and regularly monitor their iron levels to prevent complications associated with iron overload.